US 9943604
Targeted therapeutic nucleosides and their use
granted A61KA61K31/7008A61K31/7052
Quick answer
US patent 9943604 (Targeted therapeutic nucleosides and their use) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/7008, A61K31/7052, A61K31/706, A61K31/7064